Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 46, 93-103
Abstract
No abstract availableKeywords
Funding Information
- National Science Council of Taiwan (105-2314-B-038-080)
- Taipei Medical University (105TMU-SHH-04)
- Taipei Medical University
- National Taiwan University of Science and Technology (TMU-NTUST-103-03)
This publication has 20 references indexed in Scilit:
- Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinomaCancer Letters, 2015
- Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicityCancer Letters, 2015
- Cancer Stem Cells: The Promise and the PotentialSeminars in Oncology, 2015
- Revisiting STAT3 signalling in cancer: new and unexpected biological functionsNature Reviews Cancer, 2014
- Cancer stem cells: perspectives for therapeutic targetingCancer Immunology, Immunotherapy, 2014
- Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal–Epithelial Transition in Head and Neck Cancer CellsCancer Research, 2013
- Ovatodiolide Targetsβ-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell CarcinomaEvidence-Based Complementary and Alternative Medicine, 2013
- Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell linesBiochemical and Biophysical Research Communications, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Identification of cisplatin‐resistance related genes in head and neck squamous cell carcinomaInternational Journal of Cancer, 2009